Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension

OBJECTIVE: To study the effect of botulinum neurotoxin (BoNT) treatment in jerky and tremulous functional movement disorders (FMD). METHODS: Patients with invalidating, chronic (>1 year) symptoms were randomly assigned to two subsequent treatments with BoNT or placebo every 3 months with stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreissen, Yasmine Emma Maria, Dijk, Joke M, Gelauff, Jeannette M, Zoons, Evelien, van Poppelen, Daniël, Contarino, Maria Fiorella, Zutt, Rodi, Post, Bart, Munts, Alexander G, Speelman, Johannes D, Cath, Danielle C, de Haan, Rob J, Koelman, Johannes HTM, Tijssen, Marina A J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Movement Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860905/
https://www.ncbi.nlm.nih.gov/pubmed/31221722
http://dx.doi.org/10.1136/jnnp-2018-320071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860905/
https://www.ncbi.nlm.nih.gov/pubmed/31221722
http://dx.doi.org/10.1136/jnnp-2018-320071

Ejemplares similares